BlackRock Inc. grew its stake in Calyxt Inc (NASDAQ:CLXT) by 21.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 733,554 shares of the company’s stock after purchasing an additional 131,265 shares during the period. BlackRock Inc. owned approximately 2.27% of Calyxt worth $13,696,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in the company. Perkins Capital Management Inc. bought a new stake in shares of Calyxt in the 2nd quarter valued at approximately $833,000. Wells Fargo & Company MN grew its stake in shares of Calyxt by 23.6% in the 1st quarter. Wells Fargo & Company MN now owns 38,048 shares of the company’s stock valued at $500,000 after purchasing an additional 7,260 shares during the period. Finally, Granite Investment Partners LLC bought a new stake in shares of Calyxt in the 2nd quarter valued at approximately $216,000. Institutional investors own 28.00% of the company’s stock.
Several equities research analysts have recently weighed in on the company. Zacks Investment Research upgraded Calyxt from a “hold” rating to a “buy” rating and set a $15.00 price objective on the stock in a research note on Thursday, October 11th. Goldman Sachs Group initiated coverage on Calyxt in a report on Friday, September 7th. They issued a “neutral” rating and a $18.00 target price on the stock. Finally, ValuEngine raised Calyxt from a “hold” rating to a “buy” rating in a report on Friday, July 20th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $23.25.
Shares of CLXT opened at $12.04 on Thursday. The company has a market capitalization of $394.63 million, a PE ratio of -10.75 and a beta of 3.61. The company has a debt-to-equity ratio of 0.16, a quick ratio of 21.27 and a current ratio of 21.27. Calyxt Inc has a one year low of $11.42 and a one year high of $27.23.
Calyxt (NASDAQ:CLXT) last announced its earnings results on Wednesday, August 1st. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.22) by ($0.03). The business had revenue of $0.20 million during the quarter, compared to analyst estimates of $0.10 million. Calyxt had a negative return on equity of 45.34% and a negative net margin of 7,253.78%. On average, sell-side analysts expect that Calyxt Inc will post -1.01 EPS for the current fiscal year.
In other news, insider Daniel F. Voytas sold 4,083 shares of the business’s stock in a transaction that occurred on Tuesday, October 9th. The stock was sold at an average price of $13.84, for a total value of $56,508.72. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Manoj Sahoo sold 2,521 shares of the business’s stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $14.84, for a total value of $37,411.64. The disclosure for this sale can be found here. Insiders sold a total of 25,219 shares of company stock worth $402,335 over the last three months. 2.80% of the stock is owned by company insiders.
Calyxt Company Profile
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans.
Featured Article: Short Selling Stocks, A Beginner’s Guide
Want to see what other hedge funds are holding CLXT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Calyxt Inc (NASDAQ:CLXT).
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.